Followers | 679 |
Posts | 141062 |
Boards Moderated | 36 |
Alias Born | 03/10/2004 |
Friday, January 01, 2021 12:14:11 PM
By: MarketBeat | December 31, 2020
Equities research analysts forecast that Okta, Inc. (NASDAQ:OKTA) will post ($0.01) earnings per share for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have made estimates for Okta's earnings, with the highest EPS estimate coming in at ($0.01) and the lowest estimate coming in at ($0.02). Okta also posted earnings per share of ($0.01) in the same quarter last year. The company is expected to announce its next quarterly earnings report on Thursday, March 4th.
According to Zacks, analysts expect that Okta will report full-year earnings of $0.04 per share for the current year, with EPS estimates ranging from $0.03 to $0.05. For the next year, analysts anticipate that the firm will report earnings of ($0.17) per share, with EPS estimates ranging from ($0.54) to $0.11. Zacks' EPS calculations are a mean average based on a survey of sell-side analysts that that provide coverage for Okta.
Okta (NASDAQ:OKTA) last posted its earnings results on Tuesday, December 1st. The company reported $0.04 EPS for the quarter, topping analysts' consensus estimates of ($0.01) by $0.05. The business had revenue of $217.40 million for the quarter, compared to analysts' expectations of $203.15 million. Okta had a negative net margin of 31.38% and a negative return on equity of 31.29%. The business's revenue for the quarter was up 42.1% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.07) earnings per share.
A number of equities research analysts have weighed in on OKTA shares. Canaccord Genuity upped their price target on shares of Okta from $218.00 to $250.00 and gave the company a "hold" rating in a report on Thursday, December 3rd. Oppenheimer upped their price target on shares of Okta from $250.00 to $295.00 in a report on Thursday, December 3rd. Piper Sandler upped their price target on shares of Okta from $225.00 to $250.00 in a report on Thursday, December 3rd. Morgan Stanley upped their price target on shares of Okta from $231.00 to $250.00 and gave the company an "equal weight" rating in a report on Thursday, December 3rd. Finally, Mizuho upped their price target on shares of Okta from $255.00 to $270.00 and gave the company a "neutral" rating in a report on Thursday, December 3rd. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of "Buy" and an average target price of $242.55.
Read Full Story »»»
DiscoverGold
Information posted to this board is not meant to suggest any specific action, but to point out the technical signs that can help our readers make their own specific decisions. Caveat emptor!
• DiscoverGold
Recent OKTA News
- Okta to Announce First Quarter Fiscal Year 2025 Financial Results on May 29, 2024 • Business Wire • 05/01/2024 12:00:00 PM
- Canada’s Identity Theft Worries Mount with AI Progression, Okta Survey Finds • GlobeNewswire Inc. • 03/26/2024 12:00:00 PM
- Okta Ventures Unveils "The Identity 25" to Honor Pioneers Shaping the Future of Digital Identity • Business Wire • 03/19/2024 12:00:00 PM
- Okta Announces Availability of Fine Grained Authorization for Enhanced Security and Efficiency • Business Wire • 03/05/2024 01:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/01/2024 09:02:15 PM
- Okta to Present at Upcoming Investor Conferences • Business Wire • 02/29/2024 01:00:00 PM
- Snowflake Stock Plummets 20.3% After CEO Transition; C3.ai, Okta, and Duolingo Surge Post-Strong Quarterly Reports, and More • IH Market News • 02/29/2024 11:09:45 AM
- Okta Strengthens Go to Market Leadership with Executive Appointments • Business Wire • 02/28/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:02:31 PM
- Okta Announces Fourth Quarter And Fiscal Year 2024 Financial Results • Business Wire • 02/28/2024 09:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 10:17:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/16/2024 09:01:16 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:47:19 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:46:15 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 10:02:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:39:00 PM
- Okta to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on February 28, 2024 • Business Wire • 02/01/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/18/2024 11:37:34 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/16/2024 09:14:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 09:55:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:13:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:11:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:09:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:07:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:05:59 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM